Cadila inks pact with Italian firm to launch generic product in US

The partners plan to launch the product which is a generic version of Sanofi Aventis's Lovenox (Enoxaparin Sodium Injection) in seven dosage strengths in the US, the statement said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news